HP-NAP may act as a variety of therapeutic agents, including a component of vaccines against H. pylori infection, a vaccine adjuvant, a drug candidate against allergic diseases, and an immunotherapeutic agent for cancer. The gene discussed is CTNNBL1; the disease is allergic disease.